购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Apoptosis
    (3)
  • Raf
    (3)
  • 5-HT Receptor
    (1)
  • ATPase
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (19)
  • 5日内发货
    (32)
  • 20日内发货
    (5)
  • 35日内发货
    (5)
筛选
搜索结果
TargetMol产品目录中 "

b-29

"的结果
  • 抑制剂&激动剂
    35
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    22
    TargetMol | Recombinant_Protein
  • 多肽产品
    2
    TargetMol | Peptide_Products
  • 染料试剂
    2
    TargetMol | Dye_Reagents
  • PROTAC
    1
    TargetMol | PROTAC
  • 天然产物
    7
    TargetMol | Natural_Products
  • 同位素
    1
    TargetMol | Isotope_Products
  • 检测抗体
    15
    TargetMol | Antibody_Products
  • cb29
    CB-29, CB 29
    T25209315239-63-5In house
    CB29 是醛脱氢酶 3A1 (ALDH3A1) 的特异性抑制剂。
    • ¥ 993
    现货
    规格
    数量
  • UMB298
    T91942266569-73-5
    UMB298 是一种有效的选择性 CBP P300 溴结构域抑制剂,抑制 BRD4,IC50 为 5193nM。
    • ¥ 581
    现货
    规格
    数量
    TargetMol | Inhibitor Sale
  • Dynorphin B 29 (pig)
    Leumorphin (pig)
    T8251884376-30-7
    Dynorphin B 29 (Leumorphin) (pig) 是一种可与大脑及孤立组织系统中的多种受体交互作用的肽,并可被用于研究免疫反应。
    • 待询
    规格
    数量
  • CGP-11130 HCl
    T719111858241-03-8
    4-Fluorophenibut (developmental code name CGP-11130; also known as β-(4-fluorophenyl)-γ-aminobutyric acid or β-(4-fluorophenyl)-GABA) is a GABAB receptor agonist which was never marketed. It is selective for the GABAB receptor over the GABAA receptor (IC50 = 1.70 μM and > 100 μM, respectively). The drug is a GABA analogue and is closely related to baclofen (β-(4-chlorophenyl)-GABA), tolibut (β-(4-methylphenyl)-GABA), and phenibut (β-phenyl-GABA). It is less potent as a GABAB receptor agonist than baclofen but more potent than phenibut.
    • 待估
    35日内发货
    规格
    数量
  • NGB 2904
    NGB-2904, NGB2904
    T28167189060-98-8
    NGB 2904 是一种具有口服活性的、选择性的多巴胺(DA) D3受体拮抗剂,可用于具可卡因成瘾。
    • ¥ 198
    现货
    规格
    数量
    TargetMol | Inhibitor Sale
  • SB290157 trifluoroacetate
    T128511140525-25-2
    SB290157 trifluoroacetate 是一种选择性 C3a 受体拮抗剂,IC50值为200 nM。
    • ¥ 223
    现货
    规格
    数量
  • frovatriptan succinate
    SB209509 succinate, Frovatriptan Succinate anhydrous
    T21407158930-09-7
    Frovatriptan Succinate is a synthetic triptan with 5-HT1B 1D receptors agonist activity. It is indicated for the acute treatment of migraine.
    • ¥ 12800
    1-2周
    规格
    数量
  • TAB29
    T130642361144-71-8
    TAB29 is a potent peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) inhibitor (IC50 of 874 nM), with therapeutic potential for human cancers.
    • ¥ 10600
    6-8周
    规格
    数量
  • DB293
    T69857216308-19-9
    DB293 is an inhibitor of PIT-1 and BRN-3 transcription factors. DB293 binds as head-to-tail stacked dimers in the minor groove of 5'-ATGA sequence, thereby leading to an increase in the size of minor groove.
    • ¥ 10600
    6-8周
    规格
    数量
  • Pralurbactam
    T698562163782-59-8
    Pralurbactam 是 β -内酰胺酶抑制剂。Pralurbactam 可用于细菌感染的研究。
    • 待询
    6-8周
    规格
    数量
  • ngb 2904 hydrochloride
    T23065189061-11-8
    dopamine D3 receptor antagonist
    • 待估
    35日内发货
    规格
    数量
  • SB297006
    SB 297006
    T467458816-69-6
    SB297006 是一种CCR3拮抗剂,IC50为39 nM。它能够显著抑制 CCL11 处理的神经祖细胞的增殖和神经球形成。
    • ¥ 197
    现货
    规格
    数量
  • Lupeol
    羽扇豆醇, Monogynol B, Farganasterol, Fagarasterol, Clerodol, (3β,13ξ)-Lup-20(29)-en-3-ol
    T2895545-47-1
    Lupeol (Monogynol B) 是一个活跃的五环三萜,具有抗氧化剂、抗肿瘤和抗炎活性。它是一种雄激素受体抑制剂,可研究癌症,特别是雄激素依赖表型和去势抵抗表型的前列腺癌。
    • ¥ 255
    现货
    规格
    数量
    TargetMol | Citations 客户已引用
  • Alisertib
    MLN 8237, 4-[[9-氯-7-(2-氟-6-甲氧基苯基)-5H-嘧啶并[5,4-D][2]苯并氮杂卓-2-基]氨基]-2-甲氧基苯甲酸
    T22411028486-01-2
    Alisertib (MLN 8237) 是一种 Aurora A 激酶抑制剂 (IC50=1.2 nM),具有口服活性和选择性。Alisertib 具有抗肿瘤活性,可以诱导细胞凋亡和自噬,诱导细胞周期阻滞。
    • ¥ 248
    现货
    规格
    数量
    TargetMol | Citations 客户已引用
  • 7,10-dihydroxy-8(E)-Octadecenoic Acid
    T36431131021-99-3
    7,10-dihydroxy-8(E)-Octadecenoic acid is a hydroxy fatty acid and metabolite of oleic acid that is produced byP. aeruginosafrom vegetable oils.1It is active against the food-borne pathogenic bacteriaS. aureus,S. typhimurium,L. monocytogenes,B. subtilis, andE. coli(MIC50s = 31.3, 125, 125, 62.5, and 250 μg ml, respectively), as well as the plant pathogenic bacteriaErwinia,R. solanacearum,C. glutamicum, andP. syringae(MIC90s = 125, 125, 250, and 500 μg ml, respectively).2,1 1.Sohn, H.-R., Bae, J.-H., Hou, C.T., et al.Antibacterial activity of a 7,10-dihydroxy-8(E)-octadecenoic acid against plant pathogenic bacteriaEnzyme Microb. Technol.53(3)152-153(2013) 2.Chen, K.Y., Kim, I.H., Hou, C.T., et al.Monoacylglycerol of 7,10-dihydroxy-8(E)-octadecenoic acid enhances antibacterial activities against food-borne bacteriaJ. Agric. Food Chem.67(29)8191-8196(2019)
    • ¥ 4980
    期货
    规格
    数量
  • Pulsatilloside E
    白头翁皂苷E, Pulchinenoside E, 3-O-B-D-葡萄糖( 1→4)-[ A -L-鼠李糖(1→2)]- A-L-阿拉伯糖 23-羟基羽扇豆20(29)-烯-28–酸- 28-O-鼠李糖(1→4)葡萄糖(1→6)葡萄糖苷
    TN2117366814-43-9
    Pulsatilloside E (Pulchinenoside E) 是一种从毛茛科白头翁Pulsatilla chinensis (Ranunculaceae)的根中分离出来的天然产物。
    • ¥ 825
    现货
    规格
    数量
    TargetMol | Inhibitor Sale
  • Thiocoraline
    T36096173046-02-1
    Thiocoraline is a depsipeptide and DNAbis-intercalator originally isolated fromMicromonosporawith antibacterial and anticancer activities.1,2It is active against the Gram-positive bacteriaS. aureus,B. subtilis, andM. luteus(MICs = 0.05, 0.05, and 0.03 μg ml, respectively) but not Gram-negativeE. coli,K. pneumoniae, orP. aeruginosa(MICs = >100 μg ml for all).1Thiocoraline inhibits RNA and DNA polymerase and thymidylate synthase (IC50s = 6, 6, and 15 μg ml, respectively), as well as RNA and DNA synthesisin vitro(IC50s = 0.008 and 0.4 μg ml, respectively). It is cytotoxic to P388, A549, HT-29, and MEL-28 cancer cells (IC50s = 0.002, 0.002, 0.01, and 0.002 μg ml, respectively). 1.Romero, F., Espilego, F., Pérez Baz, J., et al.Thiocoraline, a new depsipeptide with antitumor activity produced by a marine Micromonospora. I. Taxonomy, fermentation, isolation, and biological activitiesJ. Antibiot. (Tokyo)50(9)734-737(1997) 2.Negri, A., Marco, E., García-Hernández, V., et al.Antitumor activity, X-ray crystal structure, and DNA binding properties of thiocoraline A, a natural bisintercalating thiodepsipeptideJ. Med. Chem.50(14)3322-3333(2007)
    • ¥ 2900
    35日内发货
    规格
    数量
  • AZD8797
    KAND567, KAN-0440567
    T14384911715-90-7
    AZD8797 (KAND567) 是一种可口服且具有选择性和有效性的人 CX3CR1 变构拮抗剂,对 CX3CR1 和 CXCR2 具有抑制作用,对SARS-CoV-2诱导的神经元损伤有潜在的保护作用,可防止癫痫发作后偏头痛模型大鼠痛觉过敏和小胶质细胞活化的恶化。
    • ¥ 1090
    现货
    规格
    数量
  • Isocucurbitacin B
    异葫芦素B
    TN177617278-28-3
    Isocucurbitacin B 对 HeLa 和 HT-29 人类癌细胞具有显着的抑制活性,IC50 值范围为 0.93 至 9.73uM。
    • ¥ 2045
    现货
    规格
    数量
  • CypD-IN-29
    T719971115335-95-9
    CypD-IN-29 is a non-peptidic inhibitor of cyclophilin D as a neuroprotective agent in Aβ-induced mitochondrial dysfunction.
    • ¥ 10600
    6-8周
    规格
    数量
  • protac braf-v600e degrader-1
    Compound 23
    T87452417296-84-3
    PROTAC BRAF-V600E degrader-1 (Compound 23) 选择性地诱导 BRAF-V600E 的降解,而不是野生型 BRAF。
    • ¥ 1130
    现货
    规格
    数量
  • N-desmethyl Regorafenib N-oxide
    T84977835621-12-0
    N-Desmethyl Regorafenib N-oxide, an active metabolite of the multi-kinase inhibitor regorafenib, originates through the action of the cytochrome P450 (CYP) isoform CYP3A4. This compound demonstrates efficacy in vitro by inhibiting key enzymes such as VEGFR2, Tie2, c-Kit, and B-RAF, and it exhibits tumor growth inhibition in HT-29 and MDA-MB-231 mouse xenograft models at a dosage of 1 mg/kg.
    • 待询
    8-10周
    规格
    数量
  • MAO-B-IN-29
    T86858122823-57-8
    MAO-B-IN-29(化合物9a)为MAO-B活性抑制剂。
    • 待询
    10-14周
    规格
    数量
  • Flumequine-13C3
    Flumequine-13C3
    T360211185049-09-5
    Flumequine-13C3is intended for use as an internal standard for the quantification of flumequine by GC- or LC-MS. Flumequine is a fluoroquinolone antibiotic.1It is active againstS. aureus, S. pyogenes, B. subtilis, E. coli, P. aeruginosa, S. faecalis, andK. pneumoniae(MICs = 1-100 μg ml). Flumequine is also active against field isolates of B. hyodysenteriae (MICs = 6.25-200 μg ml).2It inhibits DNA gyrase, disrupting supercoiling of bacterial DNA to block transcription and replication.3In vivo, flumequine (50 mg kg) increases survival in rat models ofP. vulgaris-induced urinary tract infection andP. mirabilis-induced prostatitis.1Formulations containing flumequine have been used in the treatment of urinary tract infections in veterinary medicine. 1.Rohlfing, S.R., Gerster, J.R., and Kvam, D.C.Bioevaluation of the antibacterial flumequine for urinary tract useAntimicrob. Agents Chemother.10(1)20-24(1976) 2.Aller-Morán, L.M., Martínez-Lobo, F.J., Rubio, P., et al.Evaluation of the in vitro activity of flumequine against field isolates of Brachyspira hyodysenteriaeRes. Vet. Sci.10351-53(2015) 3.Smith, J.T.The mode of action of 4-quinolones and possible mechanisms of resistanceJ. Antimicrob. Chemother.18 (Suppl. D)21-29(1986)
    • ¥ 3510
    35日内发货
    规格
    数量